Showing results (41-50 of 228) with videos related to
Sort By:
Pageof 23
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient managementCarlos M Franco, Leslie L Popplewell, Steven M HorwitzClinical Advances in Hematology & Oncology : H&O|February 25, 2012
Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, HawaiiBruce D Cheson, Steven M Horwitz, Dennis D WeisenburgerBlood|March 12, 2014
How I treat the peripheral T-cell lymphomasAlison J Moskowitz, Matthew A Lunning, Steven M HorwitzCancer Journal (Sudbury, Mass.)|September 26, 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longAlison J Moskowitz, Matthew A Lunning, Steven M HorwitzCurrent Treatment Options in Oncology|June 10, 2023
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging DirectionsRobert Stuver, Steven M Horwitz, Zachary D Epstein-PetersonBlood|February 2, 2024
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)Alison J Moskowitz, Robert N Stuver, Steven M HorwitzEbiomedicine|July 31, 2019
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaJared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al.Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Current treatment of peripheral T-cell lymphomaSteven M Horwitz, Bertrand Coiffier, Eric D Hsi, et al.Cancer Treatment and Research|January 1, 2019
Angioimmunoblastic T-Cell LymphomaMariko Yabe, Ahmet Dogan, Steven M Horwitz, et al.Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.Pageof 23